Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2026Cancer Immunology ImmunotherapyOpen Access

Depletion of CCR8+ Treg cells restores dendritic cell function to drive anti-tumor immunity

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMasaki HagiwaraAUAzumi UeyamaKMKoichi Morishita

Discussion

Loading...

Member takes

Overview

Preclinical study demonstrates that depleting CCR8+ Treg cells restores dendritic cell activation in colorectal cancer models, indicating a mechanism to reactivate antitumor immune responses.

Key Points

  • To determine the cellular mechanisms by which targeted depletion of CCR8+ regulatory T cells relieves tumor immunosuppression and promotes anti-tumor immunity.
  • Evaluated anti-CCR8 antibody treatment in a murine colon carcinoma model using single-cell RNA sequencing and spatial transcriptomics.
  • Assessed dendritic cell maturation and CD8+ T-cell priming in tumor-draining lymph nodes alongside lymphocyte egress dependence.
  • Analyzed spatial associations between CCR8+ regulatory T cells and LAMP3+ dendritic cells using multiplex immunohistochemistry in human colorectal cancer tissues.
  • CCR8+ Treg depletion rapidly upregulated costimulatory and activation markers on intratumoral mregDCs while shifting their proximity away from suppressive Tregs toward effector CD4+ and CD8+ T cells.
  • Migratory dendritic cells in tumor-draining lymph nodes exhibited enhanced maturation and robustly primed tumor-specific CD8+ T cells, with therapeutic efficacy dependent on lymphocyte egress.
  • Multiplex imaging in human colorectal cancer demonstrated spatial colocalization between CCR8+ Tregs and LAMP3+ DCs, confirming the clinical relevance of the axis.

Cite This Study

Hagiwara et al. (2026) studied this question.

synapsesocial.com/papers/6a895f62ca7ade938187dff1https://doi.org/10.1007/s00262-026-04526-5
View Full Paper
Ask AI
Bookmark
Share